1-3 of 3
Carlos Vigil, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Comorbidities and Overall Survival In Myelodysplastic Syndromes (MDS): Development of a Prognostic Model Incorporating IPSS and Age with ACE-27 Comorbidity Index

Kiran Naqvi, MD, Maria E Suarez-Almazor, MD, PhD, Sagar Sardesai, MD, Jeong Oh, MD, MPH, Carlos Vigil, MD, Sherry Pierce, RN, BS, Xiudong Lei, PhD, Jianqin Shan, PhD, Hagop M. Kantarjian, MD, Guillermo Garcia-Manero, MD
Journal: Blood
Blood (2010) 116 (21): 605.
https://doi.org/10.1182/blood.V116.21.605.605
Published: 2010
Journal Articles

Levels of Nrf2 and Keap1 Are Associated with Poor Prognostic Features In Myelodysplastic Syndromes (MDS)

Francesco Paolo Tambaro, MD, PhD, Carlos Vigil, MD, Yumin Hu, PhD, Hui Yang, MD, PhD, Zhihong Fang, Jack Yu Jia, Hong Zheng, Yue Wei, PhD, Hagop Kantarjian, MD, Lucia Altucci, MD, PhD, Felicetto Ferrara, MD, Guillermo Garcia-Manero, MD
Journal: Blood
Blood (2010) 116 (21): 1874.
https://doi.org/10.1182/blood.V116.21.1874.1874
Published: 2010
Journal Articles

Hypomethylating Therapy for the Treatment of Acute Erythroleukemia Patients.

Carlos Vigil, MD, Jorge Cortes, MD, Hagop M. Kantarjian, MD, Guillermo Garcia-Manero, MD, Jeffrey E Lancet, MD, Alan F List, MD
Journal: Blood
Blood (2009) 114 (22): 2069.
https://doi.org/10.1182/blood.V114.22.2069.2069
Published: 2009